Social Media Linked to More Satisfaction with Breast Cancer Treatment Decisions

Women who engaged on social media after a breast cancer diagnosis expressed more deliberation about their treatment decision and more satisfaction with the path they chose, a new study from the University of Michigan Comprehensive Cancer Center finds. But the researchers found significant barriers to social media for some women, particularly older women, those with less education and minorities.

"Our findings highlight an unmet need in patients for decisional support when they are going through breast cancer treatment," says lead study author Lauren P. Wallner, Ph.D., MPH, assistant professor of general medicine at the University of Michigan Medical School.

"But at this point, leveraging social media and online communication in clinical practice is not going to reach all patients. There are barriers that need to be considered," she adds.

Researchers surveyed 2,460 women newly diagnosed with breast cancer about their use of email, texting, social media and web-based support groups following their diagnosis. Women were identified through the Surveillance, Epidemiology and End Results database. The study appears in JAMA Oncology.

Overall, 41 percent of women reported some or frequent use of online communication. Texting and email were most common, with 35 percent of women using it. Twelve percent of women reported using Facebook, Twitter or other social media sites, and 12 percent used web-based support groups.

"Women reported separate reasons for using each of these modalities. Email and texting were primarily to let people know they had been diagnosed. They tended to use social media sites and web-based support groups to interact about treatment options and physician recommendations," Wallner says.

"Women also reported using all of these outlets to deal with the negative emotions and stress around their breast cancer diagnosis. They're using these communications to cope," she says.

Online communication was more common in younger women and those with more education. Use also varied by race, with 46 percent of white women and 43 percent of Asian women reporting frequent use, compared to 35 percent of black women and 33 percent of Latinas.

The researchers also found that women who frequently used online communication had more positive feelings about their treatment decision. They were more likely to report a deliberate decision and more likely to be highly satisfied with their decision.

Despite these benefits, the study authors urge caution.

"For some women, social media may be a helpful resource. But there are still questions to answer before we can rely on it as a routine part of patient care," Wallner says. "We don't know a lot about the type of information women are finding online. What are they sharing and what is the quality of that information? We need to understand that before we can really harness the potential of social media to better support patients through their cancer treatment and care."

Wallner is part of the Cancer Surveillance and Outcomes Research Team based at the University of Michigan and is a member of the university's Institute for Healthcare Policy and Innovation.

Wallner LP, Martinez KA, Li Y, et al.
Use of Online Communication by Patients With Newly Diagnosed Breast Cancer During the Treatment Decision Process.
JAMA Oncol. doi:10.1001/jamaoncol.2016.2070.

Most Popular Now

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Record Year with More than 800 Exhibit…

9 - 11 April 2024, Berlin, Germany. DMEA 2024 kicks off today, focusing on the key issues in the digital transformation of the healthcare system. From now until 11 April over...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...